Literature DB >> 24403553

Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.

Lenore Pereira1, Matthew Petitt, Alex Fong, Mitsuru Tsuge, Takako Tabata, June Fang-Hoover, Ekaterina Maidji, Martin Zydek, Yan Zhou, Naoki Inoue, Sanam Loghavi, Samuel Pepkowitz, Lawrence M Kauvar, Dotun Ogunyemi.   

Abstract

BACKGROUND: Human cytomegalovirus (HCMV) is the major viral etiology of congenital infection and birth defects. Fetal transmission is high (30%-40%) in primary maternal infection, and symptomatic babies have permanent neurological, hearing, and vision defects. Recurrent infection is infrequently transmitted (2%) and largely asymptomatic. Congenital infection is also associated with intrauterine growth restriction (IUGR).
METHODS: To investigate possible underlying HCMV infection in cases of idiopathic IUGR, we studied maternal and cord sera and placentas from 19 pregnancies. Anti-HCMV antibodies, hypoxia-related factors, and cmvIL-10 were measured in sera. Placental biopsy specimens were examined for viral DNA, expression of infected cell proteins, and pathology.
RESULTS: Among 7 IUGR cases, we identified 2 primary and 3 recurrent HCMV infections. Virus replicated in glandular epithelium and lymphatic endothelium in the decidua, cytotrophoblasts, and smooth muscle cells in blood vessels of floating villi and the chorion. Large fibrinoids with avascular villi, edema, and inflammation were significantly increased. Detection of viral proteins in the amniotic epithelium indicated transmission in 2 cases of IUGR with primary infection and 3 asymptomatic recurrent infections.
CONCLUSIONS: Congenital HCMV infection impairs placental development and functions and should be considered as an underlying cause of IUGR, regardless of virus transmission to the fetus.

Entities:  

Keywords:  HCMV; IUGR; amnion; blood vessels; chorion; congenital; fetus; placenta; pregnancy; villi

Mesh:

Substances:

Year:  2014        PMID: 24403553      PMCID: PMC3997585          DOI: 10.1093/infdis/jiu019

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions.

Authors:  Monique Bodéus; Benoît Kabamba-Mukadi; Francis Zech; Corinne Hubinont; Pierre Bernard; Patrick Goubau
Journal:  J Clin Virol       Date:  2009-12-16       Impact factor: 3.168

2.  Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.

Authors:  Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Takako Tabata; Lenore Pereira
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

3.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

4.  Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells.

Authors:  Karl W Boehme; Mario Guerrero; Teresa Compton
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

5.  Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.

Authors:  Takako Tabata; Hisaaki Kawakatsu; Ekaterina Maidji; Takao Sakai; Keiko Sakai; June Fang-Hoover; Motohiko Aiba; Dean Sheppard; Lenore Pereira
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

6.  Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection.

Authors:  Giuseppe Gerna; Antonella Sarasini; Marco Patrone; Elena Percivalle; Loretta Fiorina; Giulia Campanini; Andrea Gallina; Fausto Baldanti; M Grazia Revello
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

7.  Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.

Authors:  Naoki Nozawa; June Fang-Hoover; Takako Tabata; Ekaterina Maidji; Lenore Pereira
Journal:  J Clin Virol       Date:  2009-10-24       Impact factor: 3.168

8.  Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings.

Authors:  Garyfallia Syridou; Nicholas Spanakis; Anastasia Konstantinidou; Evangelia-Theophano Piperaki; Dimitrios Kafetzis; Efstratios Patsouris; Aris Antsaklis; Athanassios Tsakris
Journal:  J Med Virol       Date:  2008-10       Impact factor: 2.327

9.  Isolation of human placental fibroblasts.

Authors:  Dusko Ilic; Mirhan Kapidzic; Olga Genbacev
Journal:  Curr Protoc Stem Cell Biol       Date:  2008-06

10.  Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.

Authors:  Fernando A B Colugnati; Stephanie A S Staras; Sheila C Dollard; Michael J Cannon
Journal:  BMC Infect Dis       Date:  2007-07-02       Impact factor: 3.090

View more
  39 in total

1.  Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta.

Authors:  Takako Tabata; Matthew Petitt; June Fang-Hoover; Martin Zydek; Lenore Pereira
Journal:  Am J Pathol       Date:  2016-09-13       Impact factor: 4.307

2.  [A 5-year retrospective clinical study of perinatal cytomegalovirus infection].

Authors:  Li-Wei Liu; Ji-Hong Qian; Tian-Wen Zhu; Yong-Hong Zhang; Jian-Xing Zhu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-02

Review 3.  Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development.

Authors:  Laura J Yockey; Akiko Iwasaki
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

Review 4.  Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo.

Authors:  Matthew Petitt; Takako Tabata; Henry Puerta-Guardo; Eva Harris; Lenore Pereira
Journal:  Curr Opin Virol       Date:  2017-12       Impact factor: 7.090

5.  Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface.

Authors:  Yiska Weisblum; Esther Oiknine-Djian; Olesya M Vorontsov; Ronit Haimov-Kochman; Zichria Zakay-Rones; Karen Meir; David Shveiky; Sharona Elgavish; Yuval Nevo; Moshe Roseman; Michal Bronstein; David Stockheim; Ido From; Iris Eisenberg; Aya A Lewkowicz; Simcha Yagel; Amos Panet; Dana G Wolf
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 6.  Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy.

Authors:  Horst Buxmann; Klaus Hamprecht; Matthias Meyer-Wittkopf; Klaus Friese
Journal:  Dtsch Arztebl Int       Date:  2017-01-27       Impact factor: 5.594

7.  Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta.

Authors:  Takako Tabata; Matthew Petitt; Martin Zydek; June Fang-Hoover; Nicholas Larocque; Mitsuru Tsuge; Matthew Gormley; Lawrence M Kauvar; Lenore Pereira
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

8.  Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage.

Authors:  Jing Zhang; Yujing Huang; Qing Wang; Yanping Ma; Ying Qi; Zhongyang Liu; Jingui Deng; Qiang Ruan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-20       Impact factor: 3.267

Review 9.  Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections.

Authors:  Ângela C Crespo; Anita van der Zwan; João Ramalho-Santos; Jack L Strominger; Tamara Tilburgs
Journal:  J Reprod Immunol       Date:  2016-08-02       Impact factor: 4.054

10.  Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.

Authors:  Takako Tabata; Matthew Petitt; Henry Puerta-Guardo; Daniela Michlmayr; Chunling Wang; June Fang-Hoover; Eva Harris; Lenore Pereira
Journal:  Cell Host Microbe       Date:  2016-07-18       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.